The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study

The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study

The interactions between aromatase inhibitors (AI) in breast cancer (BC) and gut microbiota (GM) have not been completely established yet. The aim of the study is to evaluate the bio-diversity of GM and the relationship between GM, inflammation and tumor-infiltrating lymphocytes (TILs) in postmenopa...

Full description

Bibliographic Details
Main Authors: Angioletta Lasagna, Mara De Amici, Chiara Rossi, Valentina Zuccaro, Marta Corbella, Greta Petazzoni, Francesco Comandatore, Lucia Sacchi, Giorgia Testa, Elisa Ferraris, Gianpiero Rizzo, Richard Tancredi, Alessandra Ferrari, Marco Lucioni, Paolo Sacchi, Raffaele Bruno, Paolo Pedrazzoli
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pathogens
Subjects:
estrobolome
microbiome
TILs
breast cancer
IL17
aromatase inhibitors
Online Access:https://www.mdpi.com/2076-0817/11/12/1421

Internet

https://www.mdpi.com/2076-0817/11/12/1421

Similar Items